Zobrazeno 1 - 10
of 47
pro vyhledávání: '"M-F. TORCHET"'
Autor:
M.-F. Torchet, C. Elie, Jean-Paul Padovani, J. Mingo-Robinet, Chantal Rothschild, T. Odent, Christophe Glorion
Publikováno v:
Haemophilia. 21:e306-e311
Introduction In haemophiliacs, recurrent hemarthrosis and chronic synovitis lead to chronic arthropathy. Synovectomy is indicated when medical treatment fails. Few studies report the results of open synovectomy of the ankle in haemophiliacs with a sm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff9cc985a39ebbac3c415e5d30e78ce
https://doi.org/10.1111/hae.12704
https://doi.org/10.1111/hae.12704
Autor:
J. Faivre, M. Makhloufi, N. Salvi, J. Merckx, Albertine Aouba, Chantal Rothschild, M.-F. Torchet, M. Clairicia, D. Dazet, O. Jacqmarcq, Annie Harroche
Publikováno v:
Haemophilia. 21:465-468
Summary This study reports on 15 years of experience, in a single haemophilia care centre in France, with central venous access devices (VADs) in children with haemophilia. Following the insertion of a central VAD, patients were requested to return t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53bf265a743b81b496815b88cfec80d0
https://doi.org/10.1111/hae.12638
https://doi.org/10.1111/hae.12638
Autor:
P. Landais, F. Monge, C. Dey, Achille Aouba, M.-D. Dautzenberg, Chantal Rothschild, M.-F. Torchet, Dominique Lasne, D. Geloen, Z. Cherqaoui
Publikováno v:
Haemophilia. 18:e158-e163
Measuring von Willebrand factor (VWF) activity is essential to the diagnosis of von Willebrand disease (VWD). The VWF activity is usually assessed based on measurement of the ristocetin cofactor (VWF:RCo). However, that test is technically challengin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75f1c0606c097c78e4734d56428fd860
https://doi.org/10.1111/j.1365-2516.2011.02662.x
https://doi.org/10.1111/j.1365-2516.2011.02662.x
Autor:
A. AOUBA, G. REY, G. PAVILLON, E. JOUGLA, C. ROTHSCHILD, M-F. TORCHET, L. GUILLEVIN, O. HERMINE
Publikováno v:
Haemophilia. 18:339-344
Deaths occurring in the context of acquired haemophilia (AH) may be related to inter-connected causes and mechanisms including bleeding, specific or older patient co-morbidities or iatrogenic complications. However, their magnitude remains unknown. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ad8a30bb7b7fc91f2fbced93136eb8
https://doi.org/10.1111/j.1365-2516.2011.02647.x
https://doi.org/10.1111/j.1365-2516.2011.02647.x
Publikováno v:
Journal of Children's Orthopaedics. 4:33-37
Background In haemophiliacs, synovectomy is indicated for recurrent joint bleedings, despite medical treatment. Method We report a series of 23 surgical synovectomies of the knee with a median follow-up of 8.8 years. The median age of patients at sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329e972d84d80e43d21f34e7cd66d937
https://doi.org/10.1007/s11832-009-0229-y
https://doi.org/10.1007/s11832-009-0229-y
Publikováno v:
Haemophilia. 15:760-765
Several studies have suggested that recombinant factor VIIa (rFVIIa) is effective and safe at doses >90 microg kg(-1). In March 2007, the European Medicines Agency approved the use of single-dose rFVIIa 270 microg kg(-1) for the treatment of mild-to-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a0d6b51157af119963b87be7893eb0
https://doi.org/10.1111/j.1365-2516.2008.01968.x
https://doi.org/10.1111/j.1365-2516.2008.01968.x
Autor:
C. Gazengel, Lucienne Chatenoud, G. Beaurain, M.-F. Torchet, Christian Bréchot, C. Pasquinelli, Bach Jf, F. Laure, Daniel Zagury
Publikováno v:
British Journal of Haematology. 65:181-185
Summary. We have tested the different mononuclear blood cell populations of seven patients with severe haemophilia and one patient with F VII deficiency for the presence of HBV DNA. These subjects were all polytransfused with non-heated coagulation f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac6b4338b09b7562f0f3742b3964233d
https://doi.org/10.1111/j.1365-2141.1987.00143.x-i1
https://doi.org/10.1111/j.1365-2141.1987.00143.x-i1
Autor:
D. Barrois, Marie Dreyfus, M.‐F. Torchet, Ségolène Claeyssens, B. Arnuti, Brigitte Pautard, Jeanne-Yvonne Borg
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:1264-1266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::052fcc8f0037b97ce3dcf45518e18b18
https://doi.org/10.1111/j.1538-7836.2011.04281.x
https://doi.org/10.1111/j.1538-7836.2011.04281.x
Autor:
I. François, Laurent Frenzel, Achille Aouba, Marie-France Mamzer-Bruneel, M.-F. Torchet, Chantal Rothschild, Annie Harroche
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 21(1)
Summary The choice of plasma-derived products (PdP) vs. recombinant products (RP) for treating haemophilia is influenced by the infectious and perceived safety of the products. Batch recall of PdP due to the risk of variant Creutzfeldt-Jakob disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4c9607b1c6db1327ced40e475be77d
https://pubmed.ncbi.nlm.nih.gov/25545300
https://pubmed.ncbi.nlm.nih.gov/25545300
Publikováno v:
Revue Française des Laboratoires. 1995:121-125
Resume Il existe deux types d'hemophilie : l'hemophilie A (85 % des cas) due a un deficit en F VIII, l'hemophilie B (15 % des cas) due a un deficit en F IX. Dans les formes severes caracterisees par un taux de facteur antihemophilique inferieur ou eg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::228fe3484dae6fb2ec38bb443e2e8aff
https://doi.org/10.1016/s0338-9898(95)80070-0
https://doi.org/10.1016/s0338-9898(95)80070-0